Inventor

COMBS ANDREW P

US117 patents

⚠️ This page may combine multiple inventors who share the name “COMBS ANDREW P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

COMBS ANDREW P

INCYTE CORP

Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitors

Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors

Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-4-yl-amines as Janus kinase inhibitors

Heterocyclylamines as PI3K inhibitors

Tricyclic heterocycles as BET protein inhibitors

1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins

Pyrimidinones as PI3K inhibitors

Tricyclic heterocycles as bet protein inhibitors

Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors

1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

Modulators of indoleamine 2,3-dioxygenase and methods of using the same

Azepine inhibitors of janus kinases

1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins

1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins

Tricyclic heterocycles as BET protein inhibitors

1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins

Tricyclic heterocycles as BET protein inhibitors

Tricyclic heterocycles as bet protein inhibitors

Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-b]pyridazines and substituted imidazo[1,2-a]pyrazines as PI3K-γ inhibitors

Heterocyclylamines as PI3K inhibitors

Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors

1H-pyrrolo[2,3,c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins

Tricyclic heterocycles as BET protein inhibitors

Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors

Tricyclic heterocycles as BET protein inhibitors

Tricyclic heterocycles as bet protein inhibitors

Bicyclic heterocycles as bet protein inhibitors

Heterocyclylamines as PI3K inhibitors

Tricyclic heterocycles as BET protein inhibitors

N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors

Tricyclic heterocycles as BET protein inhibitors

Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors

Bicyclic heterocycles as BET protein inhibitors

Bicyclic azaheterocyclobenzylamines as PI3K inhibitors

Tricyclic heterocycles as BET protein inhibitors

Heterocyclylamines as PI3K inhibitors

Pyrimidinones as PI3K inhibitors

Heterocyclylamines as PI3K inhibitors

1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

Pyrimidinones as PI3K inhibitors

LI YUN-LONG

Heterocyclylamines as PI3K inhibitors

N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors

Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors

Fused pyrrole derivatives as PI3K inhibitors

COMBS ANDREW P

1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

Substituted heteroaryl fused derivatives as PI3K inhibitors

Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors

RODGERS JAMES D

Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitors

ARVANITIS ARGYRIOS G

Azepine inhibitors of Janus kinases